Literature DB >> 8079653

Opposite effects of osteogenic protein and transforming growth factor beta on chondrogenesis in cultured long bone rudiments.

S C Dieudonné1, C M Semeins, S W Goei, S Vukicevic, J K Nulend, T K Sampath, M Helder, E H Burger.   

Abstract

Osteogenic protein-1 (OP-1, also called BMP-7) is a bone morphogenetic member of the TGF-beta superfamily. In the present study, we examined the effect of recombinant human OP-1 on cartilage and bone formation in organ cultures of metatarsal long bones of mouse embryos and compared the OP-1 effects with those of human TGF-beta 1 and porcine TGF-beta 1 and beta 2. Cartilage formation was determined by measurement of longitudinal growth of whole bone rudiments during culture and by the incorporation of 35SO4 into glycosaminoglycans. Mineralization was monitored by 45Ca incorporation in the acid-soluble fraction and by measuring the length of the calcifying center of the rudiment. Toluidine blue-stained histologic sections were used for quantitative histomorphometric analysis. We found that OP-1 stimulated cartilage growth as determined by sulfate incorporation and that it increased remarkably the width of the long bones ends compared with controls. This effect was partly caused by differentiation of perichondrial cells into chondrocytes, resulting in increased appositional growth. In contrast to OP-1, TGF-beta 1 and beta 2 inhibited cartilage growth and reduced the length of whole bone rudiments compared with controls. In the ossifying center of the bone rudiments, both OP-1 and TGF-beta inhibited cartilage hypertrophy, growth of the bone collar, and matrix mineralization. These data demonstrate that OP-1 and TGF-beta exhibit opposite effects on cartilage growth but similar effects on osteogenesis in embryonic mouse long bone cultures. Since both OP-1 and TGF-beta have been demonstrated in embryonic cartilage and bone, these results suggest that they act as autocrine or paracrine regulators of embryonic bone development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8079653     DOI: 10.1002/jbmr.5650090603

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  6 in total

1.  Parathyroid hormone-related peptide (PTHrP)-dependent and -independent effects of transforming growth factor beta (TGF-beta) on endochondral bone formation.

Authors:  R Serra; A Karaplis; P Sohn
Journal:  J Cell Biol       Date:  1999-05-17       Impact factor: 10.539

2.  Parathyroid hormone and transforming growth factor-beta1 coregulate chondrocyte differentiation in vitro.

Authors:  E Nasatzky; E Azran; D D Dean; B D Boyan; Z Schwartz
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

3.  Transforming growth factor beta-1 (TGFB1) and peak bone mass: association between intragenic polymorphisms and quantitative ultrasound of the heel.

Authors:  Peter Tzakas; Betty Y L Wong; Alexander G Logan; Laurence A Rubin; David E C Cole
Journal:  BMC Musculoskelet Disord       Date:  2005-06-14       Impact factor: 2.362

4.  TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage.

Authors:  X Yang; L Chen; X Xu; C Li; C Huang; C X Deng
Journal:  J Cell Biol       Date:  2001-04-02       Impact factor: 10.539

5.  Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis.

Authors:  R Serra; M Johnson; E H Filvaroff; J LaBorde; D M Sheehan; R Derynck; H L Moses
Journal:  J Cell Biol       Date:  1997-10-20       Impact factor: 10.539

Review 6.  The Regulatory Role of Signaling Crosstalk in Hypertrophy of MSCs and Human Articular Chondrocytes.

Authors:  Leilei Zhong; Xiaobin Huang; Marcel Karperien; Janine N Post
Journal:  Int J Mol Sci       Date:  2015-08-14       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.